Perrigo to Lay Off 800, Consolidate Irish Ops to Stop Mylan Takeover

Oct 22, 2015

In order to build shareholder value and thus ward off a hostile takeover by rival generic drug maker Mylan, Perrigo will reduce its workforce by 800 employees, or approximately 6 percent of its current global headcount.

Additional actions aimed at maximizing efficiency and productivity include:

• Perrigo is taking immediate steps to consolidate its Irish operations, supply chain and procurement management activities into one global center in Ireland.

• Perrigo has announced $2 billion share repurchase plan. The plan includes $500 million of repurchases that will be completed by the end of 2015, and an additional $1.5 billion in repurchases that Perrigo expects to complete over the subsequent 24-36 months.

• Perrigo is taking actions to refine its portfolio, including commencing a sales process for the U.S. Vitamins, Minerals and Supplements  business.

Perrigo's management has rejected Mylan's tender offer -- $75 in cash and 2.3 shares of Mylan for each common share of Perrigo -- saying it significantly undervalues the company.

Read the Perrigo press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments